NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP 50 Pharmas » Pfizer back to previous page show list
TOP NEWS
Pfizer
»30/07/2009 [Company watch]
Pfizer, Fudan University ally for clinical research training

Healthcare major Pfizer is partnering with Fudan University of China to establish a graduate program in Clinical Data Management and Statistical Programming. This three year Masters Degree program, a first of its kind in China, is designed to develop qualified professionals to support clinical research which is rapidly increasing in China.

 
Healthcare major Pfizer is partnering with Fudan University of China to establish a graduate program in Clinical Data Management and Statistical Programming. This three year Masters Degree program, a first of its kind in China, is designed to develop qualified professionals to support clinical research which is rapidly increasing in China. The first group of students, who will begin classes in September this year, will study data management and statistical programming. Future students will also be trained in biostatistics, clinical sciences, clinical project management and pharmacovigilence. Mr Jeff Kindler, CEO of Pfizer, said: We believe that making a commitment to both research and training is the most effective way to foster development in China’s pharmaceutical industry. The ultimate goal of these efforts is to improve the lives of Chinese citizens by increasing access to new and effective medicines. This partnership is the latest in a series of initiatives Pfizer has been undertaking to enhance collaboration in the life sciences area in China. The ceremony was attended by representatives from the Ministry of Education, Pudong New Area of Shanghai Municipality, Shanghai Municipal Education Commission and Fudan University. This novel industry-academic collaboration features a faculty that includes Fudan professors and experts from Pfizer’s Global Research and Development network and offers students the opportunity to work on real live projects from Pfizers drug development portfolio, said Dr Lingshi Tan, General Manager of Pfizer (China) Research and Development Center. According to Prof Shaode Qin, Chancellor of Fudan University, this is the beginning of a long term Pfizer-Fudan University joint education plan to establish a ‘Pfizer-Fudan Drug Research and Development Education Center’ at Fudan University.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.